Stock market futures were essentially flat ahead of a New Year’s holiday-shortened week after President Donald Trump and ...

Their travails prove the peril of riding the coattails of a huckster with a history of running businesses that go bust.

Palantir stock is up 155% so far this year -- the third-best performance in the Nasdaq-100 -- and that follows gains of 167% ...

Federal Reserve Chair Jerome Powell has been clear that U.S. stocks are no longer cheap, and that was before the latest ...

But three AI stocks currently have similar market caps around $1.6 trillion as of this writing, and are vying to become the ...

The consumer is resilient, but the consumer is cautious. Americans are feeling down about the economy, but Americans are ...

Although the Puerto Rico deal is a good development, New Fortress Energy needs perfect execution to remain solvent, never ...

When Santa comes to town in late December for investors, it's usually a good indicator for the following year.

The following is the transcript of the interview with Bank of America Chairman and CEO Brian Moynihan that aired on "Face the ...

Novo Nordisk’s oral Wegovy wins FDA approval, outperforming rivals in weight loss. Discover why NVO stock is undervalued now.

Nvidia is on track for a 40% increase this year, but fellow tech player Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) is heading ...

Standard BioTools has a very small Wall Street following as can be seen above. On average, they expect the company to lose $0 ...